INSERM Research scientist (CRCN INSERM, permanent position)
Habilitation à diriger des recherches (HDR)
Laboratory: INMED / INSERM U1249 (Marseille, France)
http://orcid.org/0000-0002-2436-8593
2013- INSERM Research Scientist (CR1 INSERM), INSERM U901, Marseille (France)
2009-2012 INSERM Research Scientist (CR2 INSERM), INSERM U901, Marseille (France)
2008-2009 Postdoctoral fellow, INSERM U901, Marseille (France)
2006-2008 Postdoctoral fellow, Department of Physiology & Neurobiology, University of Connecticut (USA)
2005-2006 PhD student, LFCE Fellow, French league against epilepsy, Aix-Marseille University (France)
2002-2005 PhD student, MRT Fellow, Ministry for Research and Technology, Aix-Marseille University (France)
2002-2005 Lecturer, Aix-Marseille University (France)
04/2016 Habilitation à diriger des recherches, Aix-Marseille University (France)
09/2009 Postdoctoral fellow, INSERM U901 (France)
09/2008 Postdoctoral fellow, University of Connecticut (USA)
06/2006 PhD Neurosciences, Aix-Marseille University (France)
07/2001 MSc Cellular and molecular Neurobiology, Aix-Marseille University (France)
Jean-Bernard Manent, PhD is a research scientist at INMED (Institut de Neurobiologie de la Mediterranée), a Neuroscience Research Center belonging to INSERM, the French National Institute of Health and Medical Research, and to Aix-Marseille University. His research is focused on epileptogenic cortical malformations and more especially on the mechanisms responsible for seizure generation and propagation, and their consequences for cortical operation. During his career, he studied the cellular and molecular mechanisms regulating normal and pathological neuronal migration. He also gained expertise in the generation and analysis of appropriated animal models of cortical malformations causing epilepsy and intellectual disability, as well as in the design of molecular biological tools aiming at visualizing and manipulating neuronal networks. He had obtained several grants from governmental agencies and charity foundations for supporting his research and holds a permanent position at INSERM since 2009.